Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey
Korkmaz, Pinar; DEMİRTÜRK, NEŞE; Batirel, Ayse; Yardimci, Ahmet Cem; Cagir, Unal; Nemli, Salih Atakan; Korkmaz, Fatime; AKÇAM, Füsun Zeynep; BARUT, HÜSEYİN ŞENER; KARAKEÇİLİ, FARUK; Bayrak, Burcu; Tarakci, Huseyin; YULUĞKURAL, ZERRİN; Yuksel, Esma; DEMİR, NAZLIM AKTUĞ; URAL, ONUR; SÜMER, ŞUA; Harman, Rezan; Ozturk, Sinan; Tulek, Necla Eren; Kadanali, Ayten; ŞENER, ALPER; AKHAN, SILA; Keten, Derya; Karadag, Fatma Yilmaz; AYGEN, BİLGEHAN; Aydin, Gule; Sacligil, Cahide; Tanoglu, Alpaslan; Ocal, Gulfem Akengin; Arslan, Eyup; Celikbas, Aysel Kocagul; Ulcay, Asim; Karagoz, Ergenekon; SALTOĞLU, Neşe; AKDENİZ, HAYRETTİN; SIRMATEL, FATMA; Aynioglu, Aynur; Ozel, Selcan Arslan; Caylak, Selmin Dirgen; Celik, Ilhami; ALPAY, YEŞİM; Dursun, Zehra Bestepe; Bekcibasi, Muhammed; Ertem, Gunay Tuncer; Tigli, Arzu; Altunok, Elif Sargin; Suer, Kaya; Avsar, Kemal; SAYAN, MURAT
Description:
Background: Manynoninvasive methods, including aspartateaminotransaminase (AST)/alanineaminotransaminase (ALT) ratio (AAR), AST-to-platelet ratio index (APRI), Bonacini cirrhosis discriminant score (CDS), fibrosis-4 (FIB4) index, and age-platelet index (API), have been described to determine the stage of hepatic fibrosis. However, thesemethodsare developed for patients with chronic hepatitisC(CHC) andproduce conflicting results in the prediction of liver fibrosis in patients with chronic hepatitis B (CHB).
Show full item record